首页 | 本学科首页   官方微博 | 高级检索  
     

复方苦参注射液联合化疗治疗进展期非小细胞肺癌近期疗效和生存质量的Meta分析
引用本文:邢国臣. 复方苦参注射液联合化疗治疗进展期非小细胞肺癌近期疗效和生存质量的Meta分析[J]. 中国新药杂志, 2011, 0(10)
作者姓名:邢国臣
作者单位:郑州市中心医院血液肿瘤科;
摘    要:目的:比较复方苦参注射液(岩舒注射液)联合化疗与单纯化疗治疗进展期非小细胞肺癌近期疗效和生存质量的差异。方法:采用Cochrane系统评价的方法,检索万方医学文献数据库(1998-2010年),手工检索相关会议的论文集及相关试验的参考文献。评价纳入研究的方法学质量,提取有效数据,采用RevMan4.2软件进行Meta分析。结果:共纳入11项临床随机对照研究(715例患者)。Meta分析结果显示:复方苦参注射液联合化疗治疗进展期非小细胞肺癌的有效率、临床受益率、生活质量改善及减少III和IV级白细胞下降率均优于单纯化疗,其OR(95%CI)分别为1.66(1.22~2.26),2.15(1.23~3.76),2.73(1.77~4.22)和0.39(0.26~0.59)。出版偏倚分析倒漏斗图两侧基本对称;失效安全数分析若P=0.05,Nfs0.05=30例;若P=0.01,Nfs0.01=9例。结论:本研究结果倾向复方苦参注射液联合化疗治疗进展期非小细胞肺癌在近期疗效、生活质量改善方面优于单纯化疗,今后有必要开展高质量的多中心、大样本、随机、双盲临床试验进一步验证。

关 键 词:复方苦参注射液  岩舒注射液  化疗  非小细胞肺癌  Meta分析  

Meta-analysis of the quality of life and near-term efficacy after chemotherapy combined with compound Kushen injection in treating advanced non-small cell lung cancer
XING Guo-chen. Meta-analysis of the quality of life and near-term efficacy after chemotherapy combined with compound Kushen injection in treating advanced non-small cell lung cancer[J]. Chinese Journal of New Drugs, 2011, 0(10)
Authors:XING Guo-chen
Affiliation:XING Guo-chen(Department of Blood and Tumor,Zhengzhou City Center Hospital,Zhengzhou 450007,China)
Abstract:Objective: To compare the quality of life and near-term efficacy after chemotherapy combined with compound Kushen injection(Yanshu injection) to those after chemotherapy alone in treating advanced non-small cell lung cancer.Methods: Data from Wanfang database were searched and the references of related studies were checked.The textbooks and meeting reports related to Yanshu injection were manually searched.The quality of included studies was evaluated.Data were extracted into a specially designed extraction...
Keywords:compound Kushen injection  Yanshu injection  chemotherapy  non-small cell lung cancer  Meta-analysis  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号